Trevi Therapeutics
TRVI
#4785
Rank
NZ$3.78 B
Marketcap
NZ$26.56
Share price
-2.61%
Change (1 day)
28.44%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2026 (TTM): -NZ$96.82 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$80.77 Million, an increase over its 2024 earnings that were of -NZ$85.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$96.82 Million19.88%
2025 -NZ$80.77 Million-5.42%
2024 -NZ$85.4 Million67%
2023 -NZ$51.14 Million2.43%
2022 -NZ$49.93 Million-14.45%
2021 -NZ$58.36 Million1.36%
2020 -NZ$57.58 Million23.64%
2019 -NZ$46.57 Million27.54%
2018 -NZ$36.51 Million